ArriVent BioPharma, Inc.
AVBP
$22.02
-$0.84-3.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 42.93% | 6.16% | -21.09% | -44.52% | 45.53% |
| Total Receivables | -- | 1.00% | -32.67% | -42.29% | -34.30% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -54.30% | -51.62% | -35.76% | -15.75% | 10.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 175.91% | 151.77% | 67.41% | 2.84% | -14.69% |
| Total Current Assets | 46.66% | 9.86% | -18.92% | -43.27% | 41.89% |
|
|
|||||
| Total Current Assets | 46.66% | 9.86% | -18.92% | -43.27% | 41.89% |
| Net Property, Plant & Equipment | -91.56% | -73.80% | -61.19% | -52.00% | -47.08% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 105.56% | 42.86% | 283.20% | 62.96% | -95.56% |
| Total Assets | 21.18% | 11.56% | -12.74% | -34.27% | 68.57% |
|
|
|||||
| Total Accounts Payable | 56.90% | 27.70% | 6.51% | 6.49% | -16.55% |
| Total Accrued Expenses | 50.02% | 50.29% | 90.29% | 47.44% | 91.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -91.36% | -64.33% | -35.53% | -6.12% | 15.71% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 50.20% | 42.18% | 62.31% | 29.83% | 48.61% |
|
|
|||||
| Total Current Liabilities | 50.20% | 42.18% | 62.31% | 29.83% | 48.61% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -92.09% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 50.08% | 41.66% | 61.00% | 28.06% | 46.50% |
|
|
|||||
| Common Stock & APIC | 43.46% | 36.09% | 18.27% | 2.49% | 10,566.34% |
| Retained Earnings | -69.78% | -69.54% | -69.49% | -72.72% | -50.99% |
| Treasury Stock & Other | 106.64% | -- | -- | -- | -- |
| Total Common Equity | 19.24% | 9.91% | -15.77% | -36.25% | 268.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.24% | 9.91% | -15.77% | -36.25% | 268.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.24% | 9.91% | -15.77% | -36.25% | 70.30% |
|
|
|||||